256 related articles for article (PubMed ID: 1471865)
1. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine.
Jenkins IH; Fernandez W; Playford ED; Lees AJ; Frackowiak RS; Passingham RE; Brooks DJ
Ann Neurol; 1992 Dec; 32(6):749-57. PubMed ID: 1471865
[TBL] [Abstract][Full Text] [Related]
2. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study.
Playford ED; Jenkins IH; Passingham RE; Nutt J; Frackowiak RS; Brooks DJ
Ann Neurol; 1992 Aug; 32(2):151-61. PubMed ID: 1510355
[TBL] [Abstract][Full Text] [Related]
3. Pallidotomy in Parkinson's disease increases supplementary motor area and prefrontal activation during performance of volitional movements an H2(15)O PET study.
Samuel M; Ceballos-Baumann AO; Turjanski N; Boecker H; Gorospe A; Linazasoro G; Holmes AP; DeLong MR; Vitek JL; Thomas DG; Quinn NP; Obeso JA; Brooks DJ
Brain; 1997 Aug; 120 ( Pt 8)():1301-13. PubMed ID: 9278624
[TBL] [Abstract][Full Text] [Related]
4. Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine.
Rascol O; Sabatini U; Chollet F; Celsis P; Montastruc JL; Marc-Vergnes JP; Rascol A
Arch Neurol; 1992 Feb; 49(2):144-8. PubMed ID: 1736846
[TBL] [Abstract][Full Text] [Related]
5. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects.
Jahanshahi M; Jenkins IH; Brown RG; Marsden CD; Passingham RE; Brooks DJ
Brain; 1995 Aug; 118 ( Pt 4)():913-33. PubMed ID: 7655888
[TBL] [Abstract][Full Text] [Related]
6. Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease. Improvement by the dopamine agonist apomorphine.
Rascol OJ; Sabatini U; Chollet F; Montastruc JL; Marc-Vergnes JP; Rascol A
Adv Neurol; 1993; 60():419-21. PubMed ID: 8420165
[No Abstract] [Full Text] [Related]
7. Relief of akinesia by apomorphine and cerebral metabolic changes in Parkinson's disease.
Broussolle E; Cinotti L; Pollak P; Landais P; Le Bars D; Galy G; Lavenne F; Khalfallah Y; Chazot G; Mauguière F
Mov Disord; 1993 Oct; 8(4):459-62. PubMed ID: 8232355
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
[TBL] [Abstract][Full Text] [Related]
9. Effects of levodopa infusion on motor activation responses in Parkinson's disease.
Feigin A; Ghilardi MF; Fukuda M; Mentis MJ; Dhawan V; Barnes A; Ghez CP; Eidelberg D
Neurology; 2002 Jul; 59(2):220-6. PubMed ID: 12136061
[TBL] [Abstract][Full Text] [Related]
10. Effects of subthalamic nucleus stimulation on actual and imagined movement in Parkinson's disease : a PET study.
Thobois S; Dominey P; Fraix V; Mertens P; Guenot M; Zimmer L; Pollak P; Benabid AL; Broussolle E
J Neurol; 2002 Dec; 249(12):1689-98. PubMed ID: 12529791
[TBL] [Abstract][Full Text] [Related]
11. Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa.
Rascol O; Sabatini U; Chollet F; Fabre N; Senard JM; Montastruc JL; Celsis P; Marc-Vergnes JP; Rascol A
J Neurol Neurosurg Psychiatry; 1994 May; 57(5):567-71. PubMed ID: 8201325
[TBL] [Abstract][Full Text] [Related]
12. A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity.
Ceballos-Baumann AO; Boecker H; Bartenstein P; von Falkenhayn I; Riescher H; Conrad B; Moringlane JR; Alesch F
Arch Neurol; 1999 Aug; 56(8):997-1003. PubMed ID: 10448806
[TBL] [Abstract][Full Text] [Related]
13. Motor imagery in normal subjects and in asymmetrical Parkinson's disease: a PET study.
Thobois S; Dominey PF; Decety J; Pollak PP; Gregoire MC; Le Bars PD; Broussolle E
Neurology; 2000 Oct; 55(7):996-1002. PubMed ID: 11061258
[TBL] [Abstract][Full Text] [Related]
14. Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study.
Kew JJ; Leigh PN; Playford ED; Passingham RE; Goldstein LH; Frackowiak RS; Brooks DJ
Brain; 1993 Jun; 116 ( Pt 3)():655-80. PubMed ID: 8513396
[TBL] [Abstract][Full Text] [Related]
15. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa.
Haslinger B; Erhard P; Kämpfe N; Boecker H; Rummeny E; Schwaiger M; Conrad B; Ceballos-Baumann AO
Brain; 2001 Mar; 124(Pt 3):558-70. PubMed ID: 11222456
[TBL] [Abstract][Full Text] [Related]
16. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study.
Kew JJ; Goldstein LH; Leigh PN; Abrahams S; Cosgrave N; Passingham RE; Frackowiak RS; Brooks DJ
Brain; 1993 Dec; 116 ( Pt 6)():1399-423. PubMed ID: 8293278
[TBL] [Abstract][Full Text] [Related]
17. The role of language areas in motor control dysfunction in Parkinson's disease.
Albani G; Künig G; Soelch CM; Mauro A; Priano L; Martignoni E; Leenders KL
Neurol Sci; 2001 Feb; 22(1):43-4. PubMed ID: 11487193
[TBL] [Abstract][Full Text] [Related]
18. Motor imagery in Parkinson's disease: a PET study.
Cunnington R; Egan GF; O'Sullivan JD; Hughes AJ; Bradshaw JL; Colebatch JG
Mov Disord; 2001 Sep; 16(5):849-57. PubMed ID: 11746614
[TBL] [Abstract][Full Text] [Related]
19. Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease.
Payoux P; Remy P; Miloudi M; Houeto JL; Stadler C; Bejjani BP; Yelnik J; Samson Y; Rascol O; Agid Y; Damier P
J Cereb Blood Flow Metab; 2009 Feb; 29(2):235-43. PubMed ID: 18781162
[TBL] [Abstract][Full Text] [Related]
20. Apomorphine pump in advanced Parkinson's disease: Effects on motor and nonmotor symptoms with brain metabolism correlations.
Auffret M; Le Jeune F; Maurus A; Drapier S; Houvenaghel JF; Robert GH; Sauleau P; Vérin M
J Neurol Sci; 2017 Jan; 372():279-287. PubMed ID: 28017228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
